• Ramsay Générale de Santé posted revenue up 3.3% to EUR 5.4 billion, EBITDA rose 2.6% to EUR 638 million.
• Net loss attributable to shareholders narrowed to EUR 48.3 million; operating profit climbed 7.6% to EUR 186.3 million.
• Net cash flow from operations fell by EUR 169 million to EUR 525 million, on a return in working capital to more normal levels.
• Net financial debt stood at EUR 3.58 billion; net leverage pre-IFRS 16 was steady at 4.7x.
• Management flagged a July 2026 senior debt refinancing of EUR 1.75 billion; a Sept. 17 Capital Markets Day will outline its 2030 strategy.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ramsay Générale de Santé SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608261135OMX_____CNEWS_FR_GNW1001259448_fr) on August 26, 2026, and is solely responsible for the information contained therein.